Hiroaki Muguruma

Retreatment of Lung Adenocarcinoma Patients With Gefitinib Who Had Experienced Favorable Results From Their Initial Treatment With This Selective Epidermal Growth Factor Receptor Inhibitor: A Report of Three Cases

Seiji Yano, Emiko Nakataki, S. Ohtsuka et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2005 · 96 citations · Full text

Medicine, Oncology, Pharmacology +15

Follistatin Suppresses the Production of Experimental Multiple-Organ Metastasis by Small Cell Lung Cancer Cells in Natural Killer Cell–Depleted SCID Mice

Hirokazu Ogino, Seiji Yano, Soji Kakiuchi et al. · Clinical Cancer Research · 2008 · 83 citations · Full text

Medicine, Oncology, Pharmacology +14

Parathyroid hormone‐related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC‐5 cells in natural killer cell‐depleted SCID mice

Toyokazu Miki, Seiji Yano, Masaki Hanibuchi et al. · International Journal of Cancer · 2003 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +12

Reveromycin A Inhibits Osteolytic Bone Metastasis of Small-Cell Lung Cancer Cells, SBC-5, through an Antiosteoclastic Activity

Hiroaki Muguruma, Seiji Yano, Soji Kakiuchi et al. · Clinical Cancer Research · 2005 · 51 citations · Full text

Medicine, Oncology, Pharmacology +14

Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell–Depleted Severe Combined Immunodeficient Mice

Seiji Yano, Hiroaki Muguruma, Yuka Matsumori et al. · Clinical Cancer Research · 2005 · 48 citations

Medicine, Oncology, Pharmacology +17